Related Experiment Videos
HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.
Guo-Zhong Gong1, Yong-Fang Jiang, Yan He
1Center for Liver Diseases, Second Xiangya Hospital, Central South University, 86 Renmin Zhong Road, Changsha 410011, Hunan Province, China. guozhong_gong@hotmail.com
World Journal of Gastroenterology
|July 20, 2004
Summary
Hepatitis C virus NS5A protein inhibits p53 tumor suppressor activity by blocking its DNA binding. This mechanism does not alter p53 protein levels, impacting p21 gene expression.
Area of Science:
- Molecular biology
- Virology
- Cancer research
Background:
- Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is crucial for viral replication.
- The p53 tumor suppressor protein regulates cell cycle arrest and apoptosis.
- Dysregulation of p53 is implicated in various cancers, including those associated with HCV infection.
Purpose of the Study:
- To investigate the inhibitory effect of HCV NS5A on p53-mediated transactivation of the p21 promoter.
- To elucidate the mechanism by which HCV NS5A influences p53 function.
Main Methods:
- Luciferase reporter assays to measure p53 transactivation on the p21 promoter.
- Electrophoretic mobility-shift assay (EMSA) to assess p53-DNA binding.
- Western blotting to detect protein expression levels of HCV NS5A and p53.
- Transfection of hepatoma cell lines with p53 and/or HCV NS5A expression vectors.
Main Results:
- p53 significantly enhanced p21 promoter activity, confirmed by luciferase reporter assays.
- HCV NS5A dose-dependently inhibited p53 transactivation of the p21 promoter.
- EMSA demonstrated that HCV NS5A abrogated the binding affinity of p53 to its specific DNA sequence.
- p53 protein expression levels remained unaffected by HCV NS5A co-expression.
Conclusions:
- HCV NS5A inhibits p53 transactivation of the p21 promoter.
- The inhibition mechanism involves abrogating p53's DNA binding affinity.
- HCV NS5A does not affect p53 protein stability or expression levels.